Home › Sakit sa Puso at Ugat ng Dugo › Washington
Pag-aaral pangklinika para sa Sakit sa Puso at Ugat ng Dugo sa Washington
14 pag-aaral para sa Sakit sa Puso at Ugat ng Dugo ang naghahanap ng mga kalahok sa mga site sa Washington.
Mga Lungsod sa Washington
Opisyal na teksto ng pag-aaral (English)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Universal Research Group, LLC, Tacoma
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07064473A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
- Eastside Research Associates, Redmond
Nagre-recruitPhase 3
Edad 45 hanggang 80 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07613294ELEVATE-HFpEF Clinical Study
- Saint Joseph Medical Center (Tacoma WA), Tacoma
Nagre-recruit
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06678841Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- University of Washington (UW) Medical Center, Seattle
- Providence Sacred Heart Medical Center & Children's Hospital, Spokane
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT03242642Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- MultiCare Institute for Research and Innovation, Puyallup
- MultiCare Institute for Research and Innovation, Tacoma
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06909565Product Surveillance Registry
- Bremerton
- Seattle
- Spokane
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT01524276Global Paradise System US Post Approval Study
- Swedish Medical Center, Seattle
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 16, 2026 · NCT06297291CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT05931276A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma
- Seattle Children's Hospital, Seattle
Nagre-recruitObservasyonal na pag-aaral
Edad 7 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05705531A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Puyallup
- Research Site, Redmond
- Research Site, Renton
- at 2 pa
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 24, 2026 · NCT07000357OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Western Washington Medical Group, Everett
- Rainier Clinical Research Center, Renton
Nagre-recruitPhase 3
Edad 50 hanggang 105 · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07136012PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Providence Everett, Everett
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT05934487Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
- University of Washington, Seattle
- Providence Sacred Heart Medical Center, Spokane
Nagre-recruitPhase 3
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Mar 24, 2026 · NCT06217302MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
- Seattle Children's Hospital, Seattle
Nagre-recruitPhase 1
Edad 12 hanggang 25 · Lahat ng kasarian · Na-update Hun 13, 2025 · NCT05065372Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.